國立虎尾科技大學 |

Cancer Screening in Inflammatory Bowel Disease = A Guide to Risk Management and Techniques /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Cancer Screening in Inflammatory Bowel Disease / edited by Joseph D. Feuerstein, Adam S. Cheifetz.
Reminder of title:	A Guide to Risk Management and Techniques /
other author:	Feuerstein, Joseph D.
Description:	XI, 174 p. 14 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Gastroenterology . -
Online resource:	https://doi.org/10.1007/978-3-030-15301-4
ISBN:	9783030153014

Cancer Screening in Inflammatory Bowel Disease = A Guide to Risk Management and Techniques /
Cancer Screening in Inflammatory Bowel Disease A Guide to Risk Management and Techniques /[electronic resource] :edited by Joseph D. Feuerstein, Adam S. Cheifetz. - 1st ed. 2019. - XI, 174 p. 14 illus. in color.online resource.

Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases -- Screening for Colon Cancer in Inflammatory Bowel Disease -- Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease -- Female Specific Cancern Risks and Screening in Inflammatory Bowel Disease -- Lymphoma Risk and Screening in Inflammatory Bowel Disease -- Pouch Neoplasia following IPAA in Patients with Underlying Inflammatory Bowel Diseases -- Other Cancers: Small Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel Disease -- Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases -- Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical Approaches -- Cancer Risk and Screening in Pediatric Patients -- Colorectal Cancer Risk and Screening in Geriatric Patients -- Use of Biologic Drugs Following an Initial Diagnosis of Malignancy.

This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed. Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.

ISBN: 9783030153014

Standard No.: 10.1007/978-3-030-15301-4doiSubjects--Topical Terms:

1254565
Gastroenterology .

LC Class. No.: RC799-869

Dewey Class. No.: 616.33

Cancer Screening in Inflammatory Bowel Disease = A Guide to Risk Management and Techniques /
LDR:03187nam a22003975i 4500 001 1006369
003 DE-He213
005 20200703060751.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030153014 $9 978-3-030-15301-4
024 7 $a 10.1007/978-3-030-15301-4 $2 doi
035 $a 978-3-030-15301-4
050 4 $a RC799-869
072 7 $a MJH $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MJH $2 thema
082 0 4 $a 616.33 $2 23
245 1 0 $a Cancer Screening in Inflammatory Bowel Disease $h [electronic resource] : $b A Guide to Risk Management and Techniques / $c edited by Joseph D. Feuerstein, Adam S. Cheifetz.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XI, 174 p. 14 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases -- Screening for Colon Cancer in Inflammatory Bowel Disease -- Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease -- Female Specific Cancern Risks and Screening in Inflammatory Bowel Disease -- Lymphoma Risk and Screening in Inflammatory Bowel Disease -- Pouch Neoplasia following IPAA in Patients with Underlying Inflammatory Bowel Diseases -- Other Cancers: Small Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel Disease -- Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases -- Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical Approaches -- Cancer Risk and Screening in Pediatric Patients -- Colorectal Cancer Risk and Screening in Geriatric Patients -- Use of Biologic Drugs Following an Initial Diagnosis of Malignancy.
520 $a This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed. Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.
650 0 $a Gastroenterology . $3 1254565
650 0 $a Rectum—Surgery . $3 1253470
650 0 $a Oncology . $3 1253469
650 1 4 $a Gastroenterology. $3 673684
650 2 4 $a Colorectal Surgery. $3 673867
650 2 4 $a Oncology. $3 593951
700 1 $a Feuerstein, Joseph D. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1228565
700 1 $a Cheifetz, Adam S. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1228566
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030153007
776 0 8 $i Printed edition: $z 9783030153021
776 0 8 $i Printed edition: $z 9783030153038
856 4 0 $u https://doi.org/10.1007/978-3-030-15301-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)